Author: Newsdesk

Posted on

Inuvo to Present at the 8th Annual Dawson James Conference on October 12th

LITTLE ROCK, AR, Oct. 05, 2023 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, today announced that Barry Lowenthal, President and Wallace Ruiz, Chief Financial Officer of Inuvo will be participating in the 8th Annual Dawson James Conference on Thursday, October 12th, 2023, at the Wyndam Grand Jupiter at Harbourside Place in Jupiter, Florida.

Presentation details are as follows:

Event:              8th Annual Dawson James Conference

Date:               Thursday, October 12, 2023

Time:               3:00 PM ET in Track One – Preserve Ballroom C

Location:         Wyndham Grand Jupiter at Harbourside Place in Jupiter, Florida

Management will be participating in one-on-one meetings with qualified members of the investor community throughout the conference. To request a meeting, please contact [email protected]. 

About Dawson James 

Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology, Clean tech, and Consumer sectors. We are a full-service investment banking firm with research, institutional and retail sales, and execution trading and corporate services. By investing the time required to completely understand your business, we can provide an appropriate capital transaction structure and strategy including direct investment through our independent fund. Our team will assist in crafting your vision and shaping your message for the capital markets.  Headquartered in Boca Raton, FL, Dawson James is privately held with offices in New York, Maryland, and New Jersey. For more information, please visit www.dawsonjames.com.

About Inuvo

Inuvo®, Inc. (NYSE American: INUV) is a market leader in Artificial Intelligence built for advertising. Its IntentKey AI solution is a first-of-its-kind proprietary and patented technology capable of identifying and actioning to the reasons why consumers are interested in products, services, or brands, not who those consumers are. To learn more, visit www.inuvo.com.

Inuvo Company Contact:

Wally Ruiz 
Chief Financial Officer
Tel (501) 205-8397
[email protected]

Investor Relations :

David Waldman / Natalya Rudman
Crescendo Communications, LLC
Tel: (212) 671-1020


[email protected]



Posted on

EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.

SINGAPORE, Oct. 05, 2023 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering enhanced outcomes through personalized healthcare, today announced that it has signed a letter of intent dated October 4, 2023, with respect to the proposed merger with TheoremRx Inc. (“TheoremRx”), a private U.S.-based company focused on the development of new treatments with safe administration, low toxicity, and a high potential for polypharmacy usage to benefit patients suffering from cancer and women’s health conditions.

The two parties have agreed to a 30-day exclusivity period, which may be extended by an additional 15 days by mutual agreement, to negotiate and conduct due diligence with the aim of reaching a definitive agreement. Under the letter of intent, TheoremRx would merge with a subsidiary of EUDA. The legal structure, ownership stake, and name and branding after the transaction will be determined through mutual agreement during the due diligence phase.

“The proposed merger represents an exciting opportunity for EUDA to bolster its market position through the strategic combination with a biotech company with immediate growth and innovation opportunity,” said Dr. Kelvin Chen, Founder and CEO of EUDA. “We believe TheoremRx has strong access to capital and a robust pipeline of compounds addressing high-demand unmet therapeutic areas with near-term inflection points. Its project portfolio is also pre-selected for high upside, with minimal time and cost to reach key monetization milestones. By combining the respective strengths of our two companies’ platforms, we believe that we can help critical new biopharma treatments advance through the clinical trial process while creating significant value for shareholders.”

The completion of the merger is subject to various conditions, including the negotiation of a definitive agreement, regulatory approvals, and the satisfaction of customary closing conditions. There can be no assurance that the merger will be completed or that the proposed terms set forth in the letter of intent will remain unchanged.


About TheoremRx Inc.

TheoremRx Inc. is a company focused on the development of new treatments with safe administration, low toxicity, and high potential for polypharmacy usage to benefit patients suffering from cancer and women’s health conditions. TheoremRx has built a broad portfolio of novel drug candidates targeting unmet medical needs in large market indications where it will advance each asset to partnering and licensing to global pharmaceutical companies. The US-based company operates out of New York, NY and Montreal, Quebec.

TheoremRx was founded on the basis of solving two primary challenges facing biotech investors: reducing clinical risk and reducing time to value. ThereomRx’s approach maximizes upside with the least amount of time and cost to reach value inflection points. Since its inception, TheoremRx has built a portfolio of substantially de-risked clinical programs in oncology and women’s health in two primary categories:

  1. new indications of FDA-approved products (i.e., limited clinical risk; shortened regulatory pathway); and
  2. de-risked programs pre-selected for their significant efficacy signals and little-to-no side effect profiles (i.e., minimal clinical risk) which are developed only to end-of-Phase II POC.

In addition to significant novel product development successes across multiple indications, the TheoremRx management team and strategic partners have extensive experience raising capital in public and private companies, having raised over $1B in financings ranging from early-stage venture financings through crossover rounds, and capital markets transactions including PIPEs, IPOs, follow-ons, and debt financings.


About EUDA Health Holdings Limited

EUDA Health Holdings Limited is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, and improving the patient experience by delivering better outcomes through personalized healthcare. The company’s proprietary unified AI platform quickly assesses a patient’s medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. EUDA Health’s holistic approach supports patients throughout all stages of care, including wellness & prevention, urgent care & emergencies, pre-existing conditions, and aftercare services.


Forward Looking Statements

This
press release may contain “
forward-looking statements
” within
the
meaning
of
Section 27A
of the
Securities Act
of
1933 and Section 21E of
the Securities Exchange Act of 1934. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition, and stock price. Factors that could cause actual results to differ materially from management’s current expectations include those risks and uncertainties relating to our competitive position, the industry environment, potential growth opportunities, and the effects of regulation and events outside of our control, such as natural disasters, wars, or health epidemics. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions, or circumstances on which any such statement is based, except as required by law.

Contact

Christensen
Roger Hu
[email protected]
+852.2232.3968



Posted on

American Airlines Group announces webcast of third-quarter 2023 financial results

FORT WORTH, Texas, Oct. 05, 2023 (GLOBE NEWSWIRE) — American Airlines Group (NASDAQ: AAL) will webcast a live audio feed of its third-quarter 2023 financial results conference call with financial analysts and journalists on Thursday, Oct. 19, at 7:30 a.m. CT.

The webcast will be available to the public on a listen-only basis at aa.com/investorrelations. An archive of the call will be available on the website through Nov. 19.

About American Airlines Group

To Care for People on Life’s Journey®. Shares of American Airlines Group Inc. trade on Nasdaq under the ticker symbol AAL and the company’s stock is included in the S&P 500. Learn more about what’s happening at American by visiting news.aa.com and connect with American @AmericanAir and at Facebook.com/AmericanAirlines.

Investor Relations

[email protected] 



Posted on

Silicon Motion Files Notice of Arbitration Claim Against MaxLinear

TAIPEI, Taiwan and MILPITAS, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — Silicon Motion Technology Corporation (NASDAQGS: SIMO) (“Silicon Motion” or “the Company”), a global leader in designing and marketing NAND flash controllers for solid state storage devices, today commenced an arbitration against MaxLinear, Inc. for breaching its May 5, 2022 agreement to acquire the Company (the “Merger Agreement”).

The claim was filed in the Singapore International Arbitration Centre (“SIAC”), as provided under the Merger Agreement. In the arbitration, the Company seeks payment of the termination fee of $160 million, further substantial damages, interest and costs. The Company has nominated an arbitrator. Each party is entitled to nominate one arbitrator and the party-nominated arbitrators will jointly nominate a third arbitrator (or, if they fail to do so, the third arbitrator will be appointed by the SIAC).

Under the SIAC Arbitration Rules, all matters relating to the proceedings are confidential.

About Silicon Motion

Silicon Motion is the global leader in supplying NAND flash controllers for solid state storage devices. Silicon Motion supplies more SSD controllers than any other company in the world for servers, PCs and other client devices and is the leading merchant supplier of eMMC and UFS embedded storage controllers used in smartphones, IoT devices and other applications. Silicon Motion also supplies customized high-performance hyperscale data center and specialized industrial and automotive SSD solutions. Silicon Motion’s customers include most of the NAND flash vendors, storage device module makers and leading OEMs. For further information on Silicon Motion, visit www.siliconmotion.com.

FORWARD-LOOKING STATEMENTS:

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Although such statements are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on them. These statements involve risks and uncertainties, and actual market trends or our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied in these forward-looking statements for a variety of reasons. Potential risks and uncertainties include, but are not limited to the unpredictable volume and timing of customer orders, which are not fixed by contract but vary on a purchase order basis; the loss of one or more key customers or the significant reduction, postponement, rescheduling or cancellation of orders from one or more customers; general economic conditions or conditions in the semiconductor or consumer electronics markets; the impact of inflation on our business and customer’s businesses and any effect this has on economic activity in the markets in which we operate; the effects on our business and our customer’s business taking into account the ongoing US-China tariffs and trade disputes together with the uncertainties associated with any future outbreaks of COVID-19, including, but not limited to, the emergence of variants to the original COVID-19 strain; the recent increases in tensions between Taiwan and China including enhanced military activities; decreases in the overall average selling prices of our products; changes in the relative sales mix of our products; changes in our cost of finished goods; supply chain disruptions that have affected us and our industry as well as other industries on a global basis; the payment, or non-payment, of cash dividends in the future at the discretion of our board of directors and any announced planned increases in such dividends; changes in our cost of finished goods; the availability, pricing, and timeliness of delivery of other components and raw materials used in the products we sell given the current raw material supply shortages being experienced in our industry; our customers’ sales outlook, purchasing patterns, and inventory adjustments based on consumer demands and general economic conditions; any potential impairment charges that may be incurred related to businesses previously acquired or divested in the future; our ability to successfully develop, introduce, and sell new or enhanced products in a timely manner; and the timing of new product announcements or introductions by us or by our competitors. For additional discussion of these risks and uncertainties and other factors, please see the documents we file from time to time with the Securities and Exchange Commission, including our Annual Report on Form 20-F filed on April 28, 2023. We assume no obligation to update any forward-looking statements, which apply only as of the date of this press release.

Investor Contacts:  
Jason Tsai Selina Hsieh
[email protected] [email protected]
   
Media Contact:  
Dan Scorpio, H/Advisors Abernathy  
[email protected]  



Posted on

Coya Therapeutics Presents New Experimental Data Supporting the Mechanism of Action of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) at the 22nd Annual Northeast ALS (NEALS) Consortium Meeting

Coya Therapeutics Presents New Experimental Data Supporting the Mechanism of Action of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) at the 22nd Annual Northeast ALS (NEALS) Consortium Meeting

  • COYA 302 is an investigational and proprietary biologic combination with a dual immunomodulatory mechanism of action intended to enhance the anti-inflammatory function of regulatory T cells (Tregs) and suppress the inflammation produced by activated monocytes and macrophages;
  • COYA 302 is comprised of proprietary low dose interleukin-2 (LD IL-2) and CTLA-4 Ig, and is being developed for subcutaneous administration for the treatment of patients with ALS;
  • The experimental data generated in cell samples from ALS patients highlight the significant positive effect of LD IL-2/CTLA4-Ig and other Treg-enhancing therapies in reducing the inflammatory environment observed in ALS. It is known that the degree of neuroinflammation directly correlates with the severity and rate of progression observed in ALS;
  • Coya is actively planning its next clinical study to evaluate the efficacy and safety of COYA 302 in patients with ALS.

HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance the function of Tregs, announced new experimental data presented at the 22nd Annual Northeast ALS (NEALS) Consortium Meeting on October 4th, 2023. Details of the study can be found here.

Results of the in vitro study in samples from ALS patients highlight the deleterious role of M1 pro-inflammatory monocytes and macrophages in the ability of Tregs to maintain their immunomodulatory anti-inflammatory function and achieve immune homeostasis. Tregs are often dysfunctional in ALS, exhibiting low anti-inflammatory suppressive function. The degree of impaired Treg function has been shown to directly correlate with the severity and rate of progression of this life-threatening disease.

Prior studies conducted by Dr. Appel and his team at the Houston Methodist Hospital demonstrated that dysfunctional Tregs from ALS patients can be successfully expanded ex vivo restoring their suppressive function, but when Tregs were infused back to the patients the anti-inflammatory function had limited duration. Subsequent studies have identified that the inflammatory environment created by myeloid cells could be a key contributor to the loss of Treg suppressive function.

The present in vitro research work studied the interactions between expanded Tregs and activated monocytes and macrophages, and the ability of immunomodulatory drugs and other Treg-enhancing therapies to increase Treg anti-inflammatory function and suppress the pro-inflammatory function of the M1 phenotype of activated monocytes and macrophages.

Main results of the study are summarized below:

  • M1 activated monocytes and macrophages reduce Treg viability and upregulate apoptosis markers.

  • Immunomodulatory drugs known to suppress the M1 phenotype significantly decreased the production of inflammatory cytokines involved in tissue damage.

  • The combination of LD IL-2/CTLA4-Ig significantly decreased the M1 phenotype and cytokine production and maintained Treg viability.

Results of this study further support the potential of COYA 302 (LD IL-2 and CTLA4-Ig) to address the multiple pathways involved in the progression and severity of ALS. Coya is working expeditiously in the planning and execution of its next clinical study to evaluate the efficacy and safety of COYA 302 in patients with ALS.

About Coya Therapeutics, Inc.

Headquartered in Houston, TX, Coya Therapeutics, Inc. (Nasdaq: COYA) is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target systemic inflammation and neuroinflammation. Dysfunctional Tregs underlie numerous conditions including neurodegenerative, metabolic, and autoimmune diseases, and this cellular dysfunction may lead to a sustained inflammation and oxidative stress resulting in lack of homeostasis of the immune system. Coya’s investigational product candidate pipeline leverages multiple therapeutic modalities aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs. Coya’s lead therapeutic programs includes Treg-enhancing biologics (COYA 300 Series product candidates) COYA 301 and COYA 302, which are intended to enhance Treg function and expand Treg numbers. COYA 301 is a proprietary investigational recombinant human low dose IL-2 biologic for subcutaneous administration intended to enhance Treg function and expand Treg numbers in vivo, and COYA 302 is a dual-mechanism investigational biologic combination comprised of proprietary low dose IL-2 and CTLA-4 Ig. The low dose IL-2 is intended to enhance anti-inflammatory regulatory T cell function and numbers while the fusion protein CTLA-4 Ig is intended to suppress pro-inflammatory cell function. These two mechanisms may be additive or synergistic in suppressing inflammation. For more information about Coya, please visit www.coyatherapeutics.com

Forward-Looking Statements

This press release contains “forward-looking” statements that are based on our management’s beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our current and future financial performance, business plans and objectives, current and future clinical and preclinical development activities, timing and success of our ongoing and planned clinical trials and related data, the timing of announcements, updates and results of our clinical trials and related data, our ability to obtain and maintain regulatory approval, the potential therapeutic benefits and economic value of our product candidates, competitive position, industry environment and potential market opportunities. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements.

Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors including, but not limited to, those related to risks associated with the impact of COVID-19; the success, cost and timing of our product candidate development activities and ongoing and planned clinical trials; our plans to develop and commercialize targeted therapeutics; the progress of patient enrollment and dosing in our preclinical or clinical trials; the ability of our product candidates to achieve applicable endpoints in the clinical trials; the safety profile of our product candidates; the potential for data from our clinical trials to support a marketing application, as well as the timing of these events; our ability to obtain funding for our operations; development and commercialization of our product candidates; the timing of and our ability to obtain and maintain regulatory approvals; the rate and degree of market acceptance and clinical utility of our product candidates; the size and growth potential of the markets for our product candidates, and our ability to serve those markets; our commercialization, marketing and manufacturing capabilities and strategy; future agreements with third parties in connection with the commercialization of our product candidates; our expectations regarding our ability to obtain and maintain intellectual property protection; our dependence on third party manufacturers; the success of competing therapies or products that are or may become available; our ability to attract and retain key scientific or management personnel; our ability to identify additional product candidates with significant commercial potential consistent with our commercial objectives; and our estimates regarding expenses, future revenue, capital requirements and needs for additional financing.

We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Moreover, we operate in a very competitive and rapidly changing environment, and new risks may emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed herein may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Although our management believes that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. We undertake no obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Contact

David Snyder

[email protected]

Hayden IR

James Carbonara

646-755-7412

[email protected]

Media Contact

Anna Marie Imbordino

[email protected]

917-680-8765

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Posted on

El Pollo Loco Names Jill Adams New Chief Marketing Officer

The appointment underscores the chains ongoing commitment to brand marketing and digital acceleration

COSTA MESA, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — El Pollo Loco, Inc. (“El Pollo Loco” or “Company”) (Nasdaq: LOCO), the nation’s leading fire-grilled chicken restaurant chain, announced today the appointment of Jill Adams as the company’s new Chief Marketing Officer (CMO). Ms. Adams has spent over 14 years in the restaurant industry. She served as Senior Vice President of Marketing at QDOBA® Mexican Eats, leading creative, media, loyalty, product development, and CRM. Prior to joining QDOBA® Mexican Eats, Ms. Adams worked at Jack in the Box, Inc. holding various leadership roles in field marketing, product marketing, menu strategy, integrated marketing, and innovation & growth.

Most recently Ms. Adams was the Vice President of Marketing at Mister Car Wash, the largest and only public car wash in North America with over 450 locations. While at Mister Car Wash, Ms. Adams led the launch of the company’s first mobile app and e-commerce site, doubling membership in less than 3 years. She also helped drive 10 consecutive quarters of revenue and EBITDA growth.

“We are thrilled to welcome Jill into her new role at the company,” El Pollo Loco CEO Larry Roberts said. “She’s a strong and engaging leader with a proven track record leading brand strategy and marketing communications to drive growth and profitability, and her skills and talents will be a vital asset to El Pollo Loco’s marketing efforts.”

In her new role as CMO, Ms. Adams will be responsible for overseeing all marketing and brand strategy functions, including menu and new product development, advertising and public relations, digital and social media and consumer engagement for El Pollo Loco’s 492 company and franchise restaurants in seven states.

For more information, visit ElPolloLoco.com.

About El Pollo Loco 
El Pollo Loco (Nasdaq:LOCO) is the nation’s leading fire-grilled chicken restaurant with a mission to bring people together around food, family, and culture in the communities it serves. El Pollo Loco is renowned for its handcrafted food, an innovative blend of traditional Mexican cuisine and better-for-you eating. Since 1980, El Pollo Loco has successfully opened and maintained 492 company-owned and franchised restaurants in Arizona, California, Colorado, Nevada, Texas, Utah, and Louisiana while remaining true to its Mexican-American heritage. El Pollo Loco continues to grow and evolve, nourishing connections to tradition, culture, and one another through fire-grilled goodness that makes us feel like familia. For more information, visit us at ElPolloLoco.com. 

Like:
www.facebook.com/ElPolloLoco

Follow on Twitter:
@ElPolloLoco

Follow on Instagram:
@ElPolloLoco

Follow on TikTok:
@ElPolloLoco

Subscribe:
www.youtube.com/OfficialElPolloLoco

Join Loco Rewards:
www.elpolloloco.com/rewards

Join our Team:
www.elpolloloco.com/careers

MEDIA CONTACT: 

Patrick Benson
El Pollo Loco
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0e1993b2-29a1-49a9-af2c-4bd81653c283



Posted on

Texas Roadhouse, Inc. to Announce Third Quarter Earnings on October 26, 2023

LOUISVILLE, Ky., Oct. 05, 2023 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH) announced today that it will release third quarter 2023 financial results on Thursday, October 26, 2023 after the market close. A conference call will follow at 5:00 PM ET and will be webcast live from the investor relations portion of the Company’s website at www.texasroadhouse.com.

Listeners may also access the call by dialing (888) 440-5667 or (646) 960-0476 for international calls and referencing the Texas Roadhouse, Inc. Third Quarter 2023 Earnings. A replay of the call will be available until November 2, 2023 by dialing (800) 770-2030 or (647) 362-9199 for international calls.

About the Company
Texas Roadhouse is a growing restaurant company operating predominantly in the casual dining segment that first opened in 1993 and today has grown to over 720 restaurants system-wide in 49 states and ten foreign countries. For more information, please visit the Company’s Web site at www.texasroadhouse.com.

Contacts:

Investor Relations
Michael Bailen
502-515-7298

Media
Travis Doster
502-638-5457



Posted on

TheStreet and Roundtable Media Partner to Launch New Crypto Channel, Expert Network

TheStreet and Roundtable Media Partner to Launch New Crypto Channel, Expert Network

New crypto and bitcoin destination to showcase network of industry leaders, blockchain experts and independent media brands at TheStreetCrypto.com

NEW YORK–(BUSINESS WIRE)–TheStreet and Roundtable Media today announced the launch of a new partnership covering bitcoin and the blockchain industry, TheStreetCrypto.com. The partnership combines TheStreet’s extensive newsroom experience with Roundtable’s network of industry leaders, blockchain experts and independent media brands, including Bitcoin Magazine, top influencers, and advocates to provide investors with the most comprehensive understanding of the marketplace. More details and a video featuring the network experts can be found here.

The combination of Roundtable’s in-depth crypto coverage with TheStreet’s well-established audience of investors provides a unique opportunity for advertisers — the ability to reach a large audience of mainstream investors and blockchain enthusiasts on a premium media platform. TheStreet reaches an audience of more than 23 million monthly unique visitors, according to Comscore’s August 2023 U.S. rankings, and it connects with millions more through estimated daily syndication.

TheStreetCrypto.com creates the ultimate destination for exploring all things blockchain and bitcoin, providing in-depth stories, engaging video interviews, insightful expert analysis, and real-time breaking news updates.

“We believe this new destination will provide a robust and exciting experience on a daily basis and allow consumers to stay ahead of the curve in the rapidly evolving world of crypto and blockchain technology,” said Ross Levinsohn, CEO of The Arena Group, publisher of TheStreet. Sara Silverstein, editor in chief and general manager of TheStreet added; “By leveraging the authority and resources of both companies, we’re confident that we can deliver a unique and compelling experience to keep our readers informed and at the forefront of the crypto revolution.”

Roundtable CEO and founder James Heckman praised the groundbreaking nature of the new partnership. “Until now, crypto sponsors were unable to reach large-scale, high-net-worth investors in a major media environment, and typical crypto media properties lacked the major media scale and quality required to partner with mainstream financial sponsors. TheStreetCrypto connects three highly qualified and motivated audiences: sophisticated followers of Roundtable’s network of respected crypto journalists, TheStreet’s audience of mainstream and high-net-worth investors, and the die-hard followers of major crypto influencers. This unique combination creates an ideal environment to grow the industry.”

Thanks to Roundtable’s existing partnership with BTC Inc, TheStreetCrypto will be fully integrated into the largest and most respected conference in the space, the Bitcoin Conference. This event brings hundreds of sponsors together with blockchain ventures, media brands, and a fanatic audience focused on bitcoin sustainability and innovation.

“SEC Bitcoin ETFs are on the way, nations are adopting bitcoin as sovereign currency, and the U.S. reached 50 million bitcoin owners in 2023,” said David Bailey, Roundtable co-founder and CEO of BTC Inc, the parent company of Bitcoin Magazine and the Bitcoin Conference. “We’re excited about this opportunity for TheStreet and Roundtable to lead the way in educating the world about the importance and value of hard currency as a dependable asset for citizens around the world.”

Leading TheStreetCrypto.com is Peter Chawaga, former Bitcoin Magazine senior editor, known for breaking the news of El Salvador’s bitcoin legal tender announcement, and conducting the world’s first interview with Silk Road founder Ross Ulbricht after his imprisonment.

TheStreetCrypto.com will provide deep coverage of the world of bitcoin, in partnership with some of the most respected thought leaders in the space, including Bitcoin Magazine and popular educators Natalie Brunell and Robert Breedlove. In addition to Roundtable’s bitcoin focus, the broader blockchain industry will be covered by recognized and established thought leaders, including the Chamber of Digital Commerce’s Perianne Boring, Altcoin Daily, CryptosRUs, Joe Parys, and regular coverage from Roundtable’s growing network of crypto channels, including Blockleaders, Digitalist Hub, Cripto247, Monika Proffitt, Blockchain Law Alliance, Sean King, and Antelope. This insight and coverage, coupled with interviews from industry leaders like Jon Najarian, Brittany Kaiser, Kevin O’Leary, Craig Sellars, Brock Pierce, Anthony Di Iorio, Hester Peirce, and Michael Saylor, serve to educate and alert mainstream investors about the most important, profit-driving and regulatory topics. TheStreetCrypto.com provides bitcoin and crypto sponsors and ventures access to in-depth coverage in a premium environment.

Source: ComScore MMx MultiPlatform, Total Mobile 13+, U.S, August 2023

About The Arena Group

The Arena Group (NYSE American: AREN) is an innovative technology platform and media company with a proven cutting-edge playbook that transforms media brands. Our unified technology platform empowers creators and publishers with tools to publish and monetize their content, while also leveraging quality journalism of anchor brands like Sports Illustrated, TheStreet, Parade,Men’s Journal, and HubPages to build their businesses. The company aggregates content across a diverse portfolio of over 265 brands, reaching over 100 million users monthly. Visit us at thearenagroup.net and discover how we are revolutionizing the world of digital media.

About Roundtable Media Inc.

Roundtable Media, Inc. is a decentralized digital media network. Independent journalists, activists, and thought-leaders operate on a shared digital publishing, monetization, and distribution platform. Visit us at roundtable.io

MEDIA

Public Relations Manager, The Arena Group

[email protected]

Public Relations at Roundtable Media

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Blockchain Cryptocurrency Finance Media Banking Communications Professional Services Technology

MEDIA:

Logo
Logo
Posted on

LPL Financial Welcomes Bradford Capital Group

CHARLOTTE, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisors and partners Chris Bradford, CFP®, Dave Meagher and Stina Bradford have joined LPL Financial’s broker-dealer, RIA and custodial platforms. The team reported having served approximately $150 million in advisory, brokerage and retirement plan assets*, and joins LPL from Securities America, part of Osaic (formerly Advisor Group).

Based in Sacramento, Calif., Bradford Capital Group (BCG) was founded by Managing Partner Chris Bradford, who transitioned from a career as a fulltime college football coach at UC Davis to the financial services industry in 2002. Meagher teamed up with Bradford earlier this year, having built and exited several software companies prior to shifting to his career as an advisor. To support the continued growth at BCG, Stina Bradford joined the business in 2017 as Operations Manager.

“We are a dedicated team of qualified financial professionals whose main focus is to act in our clients’ best interests,” Chris Bradford said. “We provide holistic wealth analysis and financial planning, and we consider ourselves a partner to our clients as they build wealth and work toward their financial goals. At Bradford Capital Group, we never stop coaching and educating our clients to help them navigate the ever changing economy, marketplace and tax laws.”

As the industry evolves, the Bradford team decided to shift their focus to helping business owners with exit strategies and providing private wealth management services to high-net-worth families. With the shift in business, the team turned to LPL.

“By moving to LPL, we have access to an exclusive set of sophisticated services in the high-net-worth space that will enable us to offer exceptional service to clients as they build wealth and transfer it to the next generation,” Meagher said. “We appreciate that LPL gives us more flexibility and HNW options such as trust planning and concentrated wealth management, along with access to a team of specialists who support the complex issues of estate planning for HNW families.”

Scott Posner, LPL Executive Vice President, Business Development, stated, “We welcome Chris, Dave and Stina to LPL and are honored they recognized our commitment to helping advisors build their ideal practice on their own terms. We do this by providing sophisticated high-net-worth resources, innovative digital capabilities and robust business solutions designed to help them thrive. We look forward to supporting Bradford Capital Group for years to come.”


Related

Advisors, find an LPL business development representative near you.


About LPL Financial


LPL Financial Holdings Inc. (Nasdaq: LPLA) was founded on the principle that LPL should work for advisors and enterprises, and not the other way around. Today, LPL is a leader in the markets we serve, serving nearly 22,000 financial advisors, including advisors at approximately 1,100 enterprises and at approximately 550 registered investment advisor (“RIA”) firms nationwide. We are steadfast in our commitment to the advisor-mediated model and the belief that Americans deserve access to personalized guidance from a financial professional. At LPL, independence means that advisors and enterprise leaders have the freedom they deserve to choose the business model, services and technology resources that allow them to run a thriving business. They have the flexibility to do business their way. And they have the freedom to manage their client relationships, because they know their clients best. Simply put, we take care of our advisors and enterprises, so they can take care of their clients.

Securities and Advisory services offered through LPL Financial LLC (“LPL Financial”), a registered investment advisor. Member FINRA/SIPC. LPL Financial and its affiliated companies provide financial services only from the United States. Bradford Capital Group and LPL Financial are separate entities.

Throughout this communication, the terms “financial advisors” and “advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial.

We routinely disclose information that may be important to shareholders in the “Investor Relations” or “Press Releases” section of our website.

*Value approximated based on asset and holding details provided to LPL from year-end 2022.

Connect with Us!

https://twitter.com/lpl

https://www.linkedin.com/company/lpl-financial

https://www.facebook.com/LPLFinancialLLC

https://www.youtube.com/user/lplfinancialllc


Media Contact:



[email protected]


(704) 996-1840

Tracking #486580



Posted on

Regions Bank Recognized as a “Best Place to Work for Disability Inclusion”

Regions Bank Recognized as a “Best Place to Work for Disability Inclusion”

The bank’s commitment earns a score of 100 on the 2023 Disability Equality Index.

BIRMINGHAM, Ala.–(BUSINESS WIRE)–Regions Bank on Thursday announced the company has received the highest possible score of 100 on the 2023 Disability Equality Index®, the leading nonprofit resource for business disability inclusion worldwide. With this year’s distinction, Regions has now been named a “Best Place to Work for Disability Inclusion” for the third consecutive year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231005319672/en/

Based in Birmingham, Ala., Regions Bank operates branch locations throughout high-growth markets in the Southeast, Midwest and Texas. (Graphic: Business Wire)

Based in Birmingham, Ala., Regions Bank operates branch locations throughout high-growth markets in the Southeast, Midwest and Texas. (Graphic: Business Wire)

“Regions Bank has a strong commitment to providing a workplace where everyone can thrive,” said Clara Green, head of Diversity, Equity and Inclusion for Regions. “We are proud of our score of 100, but that doesn’t mean we don’t have more work to do. We want to continue to create a workplace environment where associates of all abilities feel included, and our workforce reflects the communities we serve.”

The Disability Equality Index is a joint initiative of the American Association of People with Disabilities (AAPD) and Disability:IN. Participating companies receive a score on a scale of zero to 100, with those earning 80 and above recognized as a “Best Place to Work for Disability Inclusion.” Since its inception in 2015, participation in the Disability Equality Index has grown six times – from 80 companies in the inaugural year to 485 in 2023.

Regions’ commitment to disability inclusion supports associates, customers and the communities the bank serves:

  • Regions has a dedicated Disability Services and Outreach Manager who manages external and internal outreach efforts.

  • Regions celebrates National Disability Employment Awareness Month every year by hosting educational events for associates.

  • Regions provides associates with the opportunity to self-identify as having a disability.

  • Regions is dedicated to inclusivity and accessibility for its customers, providing accessible products and services both in person and online.

About Regions Financial Corporation

Regions Financial Corporation (NYSE:RF), with $156 billion in assets, is a member of the S&P 500 Index and is one of the nation’s largest full-service providers of consumer and commercial banking, wealth management, and mortgage products and services. Regions serves customers across the South, Midwest and Texas, and through its subsidiary, Regions Bank, operates approximately 1,250 banking offices and more than 2,000 ATMs. Regions Bank is an Equal Housing Lender and Member FDIC. Additional information about Regions and its full line of products and services can be found at www.regions.com.

About the Disability Equality Index

The Disability Equality Index (DEI) is a comprehensive benchmarking tool that helps companies build a roadmap of measurable, tangible actions that they can take to achieve disability inclusion and equality. Each company receives a score, on a scale of zero (0) to 100, with those earning 80 and above recognized as a “Best Place to Work for Disability Inclusion.”

The DEI is a joint initiative of the American Association of People with Disabilities (AAPD), the nation’s largest disability rights organization, and Disability:IN, the global business disability inclusion network, to collectively advance the inclusion of people with disabilities. The organizations are complementary and bring unique strengths that make the project relevant and credible to corporations and the disability community. The tool was developed by the DEI Advisory Committee, a diverse group of business leaders, policy experts, and disability advocates. Learn more at: https://disabilityin.org/what-we-do/disability-equality-index/.

Jeremy King

Regions Bank

205-264-4551

Regions News Online: regions.doingmoretoday.com

Regions News on Twitter: @RegionsNews

KEYWORDS: Alabama United States North America

INDUSTRY KEYWORDS: Finance Banking Professional Services DEI (Diversity, Equity and Inclusion) Human Resources

MEDIA:

Logo
Logo
Photo
Photo
Based in Birmingham, Ala., Regions Bank operates branch locations throughout high-growth markets in the Southeast, Midwest and Texas. (Graphic: Business Wire)